More on PALI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/25/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Palisade Bio Inc. (NQ:PALI)
Delayed: 1.97 +0.08 (4.23%)
Prev. Close $1.89  
Open$1.86 
52 Wk High$ 
52 Wk Low$ 
Day High$2.03 
Day Low$1.84 
P/E N/A  
EPS$ 
Volume2,097,801 

Friends, Peers and Foes (?): AKTX, AMIX, CNSP, GRI, MBRX (more...)

Jul 10, 2026 06:14 PM Form 4 PALISADE BIO, INC. For: Jul 08 Filed by: Baltera Robert Jr.
Jul 10, 2026 09:00 AM Palisade Bio to Participate in the Leerink Partners Therapeutics Forum
Jul 8, 2026 06:56 PM Form 4 PALISADE BIO, INC. For: Jul 06 Filed by: Baltera Robert Jr.
Jul 8, 2026 06:53 PM Form 4 PALISADE BIO, INC. For: Jul 06 Filed by: Jones Mitchell Lawrence
Jul 8, 2026 06:49 PM Form 4 PALISADE BIO, INC. For: Jul 06 Filed by: Finley John David
Jul 7, 2026 05:19 PM Form 144 PALISADE BIO, INC. Filed by: Jones Mitchell Lawrence
Jul 7, 2026 05:00 PM Form 144 PALISADE BIO, INC. Filed by: Finley John David
Jul 6, 2026 07:48 PM Form 4 PALISADE BIO, INC. For: Jul 01 Filed by: Baltera Robert Jr.
Jun 30, 2026 06:45 AM H.C. Wainwright Reiterates Buy Rating on Palisade Bio Inc. (PALI)
Jun 29, 2026 08:30 AM Palisade Bio gets FDA clearance to begin Phase 2 UC drug trial
View All Articles

Entities mentioned with PALI

View All Entities